Hello.
I never particularly liked DuPont, its history and its products, but
whenever I went into the neurologist's office to pick up my packages of
lodosyn, I thanked DuPont. I received lodosyn, to counteract the side
effects of sinemet, for over two years, and I know others who received it for
a longer period of time. Lodosyn has to have been/has to be an "orphan
drug," and it was provided by DuPont, free of charge, for a long time. Now I
buy lodosyn at the pharmacy like any prescription drug. I can be cynical,
and say that DuPont created a ready market for lodosyn, when it did go on the
market as a regular prescription drug for sale. On the other hand, I can say
DuPont did not have to provide this orphan drug for me and others, and for
free, and for however long it did that. Sure, I ask why, why did DuPont do
this? This drug is for people with Parkinson's disease who have nausea, or
vomit, when they take sinemet: how many people is that? How much money
did/does DuPont make on lodosyn? Probably not that much.
I would like to think, and I recognize I may be naive, that not every
company, not every corporation, is motivated solely by profit, by money, all
the time. I think the thought that drug companies may be/are motivated to
forestall a treatment and/or a cure to a debilitating disease because they
will lose money from being unable to have a market for current medications is
a very clever, and provocative thought, and that thought does need to be
considered and examined, but I would like to think, I would like to hope
that somewhere someone in those big, bad drug corporations says lets make
this orphan drug and give it away for free or lets develop this drug and hope
for a treatment and/or a cure for Parkinson's Disease. Katie
----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn
